Long-term safety of gaboxadol in the treatment of elderly patients with primary insomnia: A 12month, double-blind, placebo-controlled clinical trial

被引:0
|
作者
Bodkin, J.
Anderson, D.
Zheng, Y.
Golm, G.
Gottwald, R.
Kametz, K.
机构
[1] McLean Hosp, Belmont, MA 02178 USA
[2] Anderson Clin Res, Redlands, CA USA
[3] Merck Res Labs, N Wales, PA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
702
引用
收藏
页码:A238 / A239
页数:2
相关论文
共 50 条
  • [31] Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial
    Maggie C Walter
    Peter Reilich
    Simone Thiele
    Joachim Schessl
    Herbert Schreiber
    Karlheinz Reiners
    Wolfram Kress
    Clemens Müller-Reible
    Matthias Vorgerd
    Peter Urban
    Bertold Schrank
    Marcus Deschauer
    Beate Schlotter-Weigel
    Ralf Kohnen
    Hanns Lochmüller
    [J]. Orphanet Journal of Rare Diseases, 8
  • [32] Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial
    Walter, Maggie C.
    Reilich, Peter
    Thiele, Simone
    Schessl, Joachim
    Schreiber, Herbert
    Reiners, Karlheinz
    Kress, Wolfram
    Mueller-Reible, Clemens
    Vorgerd, Matthias
    Urban, Peter
    Schrank, Bertold
    Deschauer, Marcus
    Schlotter-Weigel, Beate
    Kohnen, Ralf
    Lochmueller, Hanns
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
  • [33] Efficacy and cardiac safety of propiverine in elderly patients -: A double-blind, placebo-controlled clinical study
    Dorschner, W
    Stolzenburg, JU
    Griebenow, R
    Halaska, M
    Schubert, G
    Mürtz, G
    Frank, M
    Wieners, F
    [J]. EUROPEAN UROLOGY, 2000, 37 (06) : 702 - 708
  • [34] Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial
    Blom, Kerstin
    Forsell, Erik
    Hellberg, Monica
    Svanborg, Cecilia
    Jernelov, Susanna
    Kaldo, Viktor
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2024, 93 (02) : 100 - 113
  • [35] Aloysia citriodora Palau (lemon verbena) for insomnia patients: A randomized, double-blind, placebo-controlled clinical trial of efficacy and safety
    Afrasiabian, Farshid
    Ardakani, Mehran Mirabzadeh
    Rahmani, Khaled
    Azadi, Nammam Ali
    Alemohammad, Zahra Banafsheh
    Bidaki, Reza
    Karimi, Mehrdad
    Emtiazy, Majid
    Hashempur, Mohammad Hashem
    [J]. PHYTOTHERAPY RESEARCH, 2019, 33 (02) : 350 - 359
  • [36] A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects
    C Cercato
    V A Roizenblatt
    C C Leança
    A Segal
    A P Lopes Filho
    M C Mancini
    A Halpern
    [J]. International Journal of Obesity, 2009, 33 : 857 - 865
  • [37] A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects
    J Wilding
    L Van Gaal
    A Rissanen
    F Vercruysse
    M Fitchet
    [J]. International Journal of Obesity, 2004, 28 : 1399 - 1410
  • [38] A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects
    Wilding, J
    Van Gaal, L
    Rissanen, A
    Vercruysse, F
    Fitchet, M
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (11) : 1399 - 1410
  • [39] A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects
    Cercato, C.
    Roizenblatt, V. A.
    Leanca, C. C.
    Segal, A.
    Lopes Filho, A. P.
    Mancini, M. C.
    Halpern, A.
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2009, 33 (08) : 857 - 865
  • [40] Randomized, double-blind, placebo-controlled trial of fluoxetine treatment for elderly patients with dysthymic disorder
    Devanand, DP
    Nobler, MS
    Cheng, J
    Turret, N
    Pelton, GH
    Roose, SP
    Sackeim, HA
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 13 (01): : 59 - 68